Alliance Growers Corp. (CSE:ACG) is a Diversified Global Medical Cannabis Company driven by the Company’s ‘Four Pillars’ Organization Plan – 1-Products and Services for Cannabis and Hemp Cultivators through its strategic relationship with Pharmagreen (PHBI), the supply of starter plantlets through a proprietary tissue culture process for the CBD hemp and cannabis industries and the supply of feminized, high percentage CBD hemp seeds, 2-Strategic Alliances with Cannabis and Hemp Cultivators, including the availability of utilizing indoor and outdoor grow facilities, providing cannabis products (Alliance branded pre-rolls) and the potential for export of cannabis product. 3-CBD/THC Infused Products via “self-financed” partnerships including infused spirits and infused health related products; and 4-Research and Technology through strategic relationships with PharamaGreen and B.R.I.M., a company that has expertise in all aspects of cannabis and hemp and others.

Alliance Growers and Pharmagreen Biotech Inc. are jointly developing a Cannabis Biotech Complex, the first of its kind in Western Canada to house a Tissue Culture Production Facility, DNA Botany lab, and eventually an extraction facility and to service the Cannabis market and agriculture market in general. The main facility will grow Cannabis plantlets utilizing the proprietary “Chibafreen Invitro Plant Production System” for tissue culture propagation, allowing more tissue cultured plantlets to be produced in less space and less time. 

Asep Medical Holdings Inc. (asepmedical.com) is dedicated to addressing the global issue of antibiotic failure by developing novel solutions for significant unmet medical needs in human medicine. The Company is a consolidation of three existing private companies all with technology in advanced development — Sepset Biosciences Inc. (proprietary diagnostic tools to enable the early and timely identification of sepsis), ABT Innovations Inc. (broad-spectrum therapeutic agents to address multi-drug resistant biofilm infections), and SafeCoat Medical Inc. (an antibacterial peptide medical device coating technology). 

A breath biomarker company developing a rapid, point-of-care test to detect pulmonary infections.

Ayr is an expanding vertically integrated, U.S. multi-state cannabis operator. Based on the belief that everything starts with the quality of the plant, the Company’s mission is to cultivate the finest quality cannabis at scale and deliver remarkable experiences to its customers every day.

Ayr’s leadership team brings proven expertise in growing successful businesses through disciplined operational and financial management, and is committed to driving positive impact for customers, employees and the communities they serve. For more information, please visit www.ayrwellness.com.

Investor Note: In addition to the 60,909,492 Subordinate Voting Shares that are issued and outstanding, there are (a) 3,696,486 shares reserved for issuance pursuant to the conversion rights attached to the Multiple Voting Shares that are issued and outstanding but not listed, (b) 2,874,085 shares reserved for issuance pursuant to the exercise of unlisted warrants that are exercisable at US$9.07 per share, and (c) 6,044,339 shares reserved for issuance pursuant to the  exchange rights attached to the Exchangeable Shares that are  issued and outstanding but not listed. The total number of Subordinate Voting Shares assuming all of the foregoing are exercised or converted, as applicable, and issued would be 73,524,402. The foregoing does not include the Subordinate Voting Shares reserved for issuance pursuant to rights attached to the Restricted Exchangeable Shares granted as equity incentive compensation or rights attached to the Restricted Exchangeable shares that are available under Ayr’s long-term equity incentive plan but that have not been granted.  In addition, the 60,909,492 Subordinate Voting Shares noted above includes 645,300 shares that are held by Ayr in treasury (under applicable corporate law, they are not entitled to be voted or receive dividends).  The above numbers are effective as of December 31, 2022. References to Subordinate Voting Shares include Restricted Voting Shares and Limited Voting Shares, as applicable, as all three classes of share trade under a single stock symbol and CUSIP number.